Abstract

Background

In the treatment of tall stature, the reduction of excessive predicted final height can either be achieved by hormonal treatment or surgically by temporary (tED) or permanent (pED) epiphysiodesis. The present study evaluates the preliminary results of two novel devices for tED and pED around the knee to reduce the predicted final height.

Materials and methods

A retrospective analysis was performed to evaluate the clinical and radiographic outcome after bilateral epiphysiodesis for the treatment of tall stature. A cohort of 34 patients (16 girls, 18 boys) who underwent either tED or pED between 2015 and 2020 were eligible for analysis based on the electronic patient records and picture archiving and communication system of our orthopaedic teaching hospital. tED was conducted in 11 patients (32%) through bilateral implantation of four RigidTacks™ (Merete, Berlin, Germany) around the knee. Twenty-three patients (68%) received pED, performed with an EpiStop™ trephine (Eberle, Wurmberg, Germany). The mean overall follow-up time was 2.9 years.

Results

The mean age at surgery was 12.3 years in girls and 13.2 years in boys. Patients had a mean body height of 175.2 cm in girls and 184.7 cm in boys at surgery. The mean predicted final height was 191.4 cm in girls and 210.4 cm in boys. At the last follow-up, 26 patients (76.5%) had achieved skeletal maturity. The mean height of skeletally mature patients was 187.2 cm in girls and 198.5 cm in boys. A mean reduction of the predicted final height of 5.9 cm in girls and 8.7 cm in boys was achieved, corresponding to a reduction in remaining growth of 46% in girls and 38% in boys. Secondary frontal plane deformities of the knee were detected in 5/11 patients (45.5%) in the tED group and 1/23 treatments (4.3%) in the pED group.

Conclusions

tED and pED have both proven to be efficient at achieving growth inhibition to reduce excessive predicted height. However, tED has been associated with an increased risk of secondary angular deformities of the knee. Furthermore, the risk of implant-related complications and the necessity of a subsequent surgical intervention for implant removal have led our study group to abandon tED when treating tall stature. Long-term results of both procedures are pending.

Level of evidence

4.

Details

Title
Preliminary results of two novel devices for epiphysiodesis in the reduction of excessive predicted final height in tall stature
Author
Laufer, Andrea 1   VIAFID ORCID Logo  ; Toporowski, Gregor 1   VIAFID ORCID Logo  ; Gosheger, Georg 2   VIAFID ORCID Logo  ; von der Heiden, Ava 3 ; Rölfing, Jan Duedal 4   VIAFID ORCID Logo  ; Frommer, Adrien 1   VIAFID ORCID Logo  ; Rachbauer, Anna 1   VIAFID ORCID Logo  ; Antfang, Carina 1   VIAFID ORCID Logo  ; Rödl, Robert 3   VIAFID ORCID Logo  ; Vogt, Bjoern 3   VIAFID ORCID Logo 

 University Hospital of Muenster, Children’s Orthopaedics, Deformity Reconstruction and Foot Surgery, Muenster, Germany (GRID:grid.16149.3b) (ISNI:0000 0004 0551 4246); University Hospital of Muenster, General Orthopaedics and Tumour Orthopaedics, Muenster, Germany (GRID:grid.16149.3b) (ISNI:0000 0004 0551 4246) 
 University Hospital of Muenster, General Orthopaedics and Tumour Orthopaedics, Muenster, Germany (GRID:grid.16149.3b) (ISNI:0000 0004 0551 4246) 
 University Hospital of Muenster, Children’s Orthopaedics, Deformity Reconstruction and Foot Surgery, Muenster, Germany (GRID:grid.16149.3b) (ISNI:0000 0004 0551 4246) 
 University Hospital of Muenster, Children’s Orthopaedics, Deformity Reconstruction and Foot Surgery, Muenster, Germany (GRID:grid.16149.3b) (ISNI:0000 0004 0551 4246); Aarhus University Hospital, Children’s Orthopaedics and Reconstruction, Aarhus, Denmark (GRID:grid.154185.c) (ISNI:0000 0004 0512 597X) 
Publication year
2022
Publication date
Dec 2022
Publisher
Springer Nature B.V.
ISSN
15909921
e-ISSN
15909999
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2715167275
Copyright
© The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.